Authors:
Ho, VCY
Griffiths, CEM
Berth-Jones, J
Papp, KA
Vanaclocha, F
Dauden, E
Beard, A
Puvanarajan, L
Paul, C
Citation: Vcy. Ho et al., Intermittent short courses of cyclosporine microemulsion for the long-termmanagement of psoriasis: A 2-year cohort study, J AM ACAD D, 44(4), 2001, pp. 643-651
Authors:
Luger, T
Van Leent, EJM
Graeber, M
Hedgecock, S
Thurston, M
Kandra, A
Berth-Jones, J
Bjerke, J
Christophers, E
Knop, J
Knulst, AC
Morren, M
Morris, A
Reitamo, S
Roed-Petersen, J
Schoepf, E
Thestrup-Pedersen, K
Van der Valk, PGM
Bos, JD
Citation: T. Luger et al., SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis, BR J DERM, 144(4), 2001, pp. 788-794
Citation: S. Agarwal et J. Berth-jones, A contact dermatitis reaction to clobetasol propionate cream associated with resolution of recalcitrant, generalized granuloma annulare, J DERM TR, 11(4), 2000, pp. 279-282
Authors:
Ahmed, I
Berth-Jones, J
Charles-Holmes, S
O'Callaghan, CJ
Ilchyshyn, A
Citation: I. Ahmed et al., Comparison of cryotherapy with curettage in the treatment of Bowen's disease: a prospective study, BR J DERM, 143(4), 2000, pp. 759-766
Authors:
Harper, JI
Ahmed, I
Barclay, G
Lacour, M
Hoeger, P
Cork, MJ
Finlay, AY
Wilson, NJE
Graham-Brown, RAC
Sowden, JM
Beard, AL
Sumner, MJ
Berth-Jones, J
Citation: Ji. Harper et al., Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy, BR J DERM, 142(1), 2000, pp. 52-58
Citation: J. Berth-jones et Rac. Graham-brown, A review of the use of essential fatty acid supplementation in atopic dermatitis with emphasis on the methodology of trial design, CUTANEOUS BIOMETRICS, 2000, pp. 109-117
Authors:
Barker, JNWN
Ashton, RE
Marks, R
Harris, RI
Berth-Jones, J
Citation: Jnwn. Barker et al., Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator, BR J DERM, 141(2), 1999, pp. 274-278